A detailed history of Four Thought Financial, LLC transactions in Myovant Sciences Ltd. stock. As of the latest transaction made, Four Thought Financial, LLC holds 1,000 shares of MYOV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$0
Previous $12,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Nov 12, 2021

BUY
$13.8 - $27.62 $13,800 - $27,620
1,000 New
1,000 $27,000

Others Institutions Holding MYOV

About Myovant Sciences Ltd.


  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Four Thought Financial, LLC Portfolio

Follow Four Thought Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Four Thought Financial, LLC with notifications on news.